Asston Pharmaceuticals Limited IPO Details – Price, Date, GMP & Analysis
Asston Pharmaceuticals Limited IPO Overview
Key IPO Details
Investment Summary
The Asston Pharmaceuticals Limited IPO IPO is a sme offering scheduled to open on July 9. The issue is priced at ₹123 per share, with a minimum application of 1000 shares.
Status: Listed and trading
How to Apply for Asston Pharmaceuticals Limited IPO
To apply for the Asston Pharmaceuticals Limited IPO, you need a demat account with any SEBI-registered broker, PAN card, and UPI or bank account for payment.
Application Process
- Log into your broker's platform or app
- Navigate to IPO section and select Asston Pharmaceuticals Limited IPO
- Enter bid quantity (minimum 1000 shares)
- Choose cut-off price or enter specific price
- Make payment via UPI or ASBA
- Submit application before July 11
Required Documents
- Active demat account
- PAN card
- Bank account linked to demat
- UPI ID for payment
- Valid mobile number and email
Minimum Investment: ₹123,000(approx. based on lower price band)
Company Overview
Asston Pharmaceuticals Limited, incorporated in 2019, specializes in exporting healthcare products globally. It offers a diverse range of pharmaceuticals, including tablets, capsules, sachets, and syrups across various therapeutic categories. The company manufactures products for direct sales and contract manufacturing, adhering to high-quality standards with FDA certification and NQA accreditation. As of September 30, 2024, it employs 46 permanent and 6 contractual employees.
Grey Market Premium (GMP)
IPO Timeline
Open Date
Wed, Jul 9, 2025
CompletedClose Date
Fri, Jul 11, 2025
CompletedAllotment
Mon, Jul 14, 2025
CompletedRefund Process
Tue, Jul 15, 2025
CompletedCredit to Demat
Tue, Jul 15, 2025
CompletedListing Date
Wed, Jul 16, 2025
CompletedSubscription Status
Latest Subscription Data
| Category | Subscription | Status |
|---|---|---|
| QIB (Qualified Institutional Buyers) | 85.76x | Oversubscribed |
| NII (Non-Institutional Investors/HNI) | 353.14x | Oversubscribed |
| RII (Retail Individual Investors) | 172.06x | Oversubscribed |
| Total Subscription | 186.55x | Oversubscribed |
Last updated: Invalid Date
IPO Details
Asston Pharmaceuticals IPO Details
| IPO Date | July 9, 2025 to July 11, 2025 |
| Listing Date | July 16, 2025 |
| Face Value | ₹10 per share |
| Issue Price | ₹123 per share |
| Lot Size | 1,000 Shares |
| Sale Type | Fresh Capital |
| Total Issue Size | 22,41,000 shares (aggregating up to ₹27.56 Cr) |
| Net Offered to Public | 21,28,000 shares (aggregating up to ₹26.17 Cr) |
| Issue Type | Bookbuilding IPO |
| Listing At | BSE SME |
| Share Holding Pre Issue | 62,71,360 shares |
| Share Holding Post Issue | 85,12,360 shares |
Asston Pharmaceuticals IPO Reservation
| Investor Category | Shares Offered |
|---|---|
| Market Maker Shares Offered | 1,13,000 (7.04%) |
| QIB Shares Offered | 10,60,000 (66.00%) |
| − Anchor Investor Shares Offered | 6,35,000 (39.54%) |
| − QIB (Ex. Anchor) Shares Offered | 4,25,000 (26.46%) |
| NII (HNI) Shares Offered | 3,22,000 (20.05%) |
| − bNII > ₹10L | 2,15,000 (13.39%) |
| − sNII < ₹10L | 1,07,000 (6.66%) |
| Retail Shares Offered | 7,46,000 (46.45%) |
| Total Shares Offered | 16,06,000 (100.00%) |
Asston Pharmaceuticals IPO Timeline (Tentative Schedule)
| IPO Open Date | Wed, Jul 9, 2025 |
| IPO Close Date | Fri, Jul 11, 2025 |
| Tentative Allotment | Mon, Jul 14, 2025 |
| Initiation of Refunds | Tue, Jul 15, 2025 |
| Credit of Shares to Demat | Tue, Jul 15, 2025 |
| Tentative Listing Date | Wed, Jul 16, 2025 |
| Cut-off time for UPI mandate confirmation | 5 PM on July 11, 2025 |
Asston Pharmaceuticals IPO Lot Size
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Individual investors (Retail) (Min) | 2 | 2,000 | ₹2,46,000 |
| Individual investors (Retail) (Max) | 2 | 2,000 | ₹2,46,000 |
| S-HNI (Min) | 3 | 3,000 | ₹3,69,000 |
| S-HNI (Max) | 8 | 8,000 | ₹9,84,000 |
| B-HNI (Min) | 9 | 9,000 | ₹11,07,000 |
Asston Pharmaceuticals IPO Promoter Holding
| Share Holding Pre Issue | 68.76% |
| Share Holding Post Issue | 50.66% |
Asston Pharmaceuticals IPO Listing Details
| July 16, 2025 |
| 544445 |
| INE0SJX01015 |
| ₹123 per share |
| MT |
Financial Information
Company FinancialsAsston Pharmaceuticals Limited Financial Information (Restated)
| Period Ended | 31 May 2025 | 31 Mar 2025 | 31 Mar 2024 | 31 Mar 2023 |
| Assets | 31.83 | 28.12 | 20.26 | 13.69 |
| Revenue | 6.21 | 25.61 | 15.84 | 7.19 |
| Profit After Tax | 1.32 | 4.33 | 1.36 | 1.06 |
| EBITDA | 1.93 | 6.16 | 2.55 | 1.52 |
| Net Worth | 12.04 | 10.72 | 6.39 | 1.99 |
| Reserves and Surplus | 5.77 | 4.45 | 5.61 | 1.29 |
| Total Borrowing | 7.83 | 7.26 | 6.82 | 5.25 |
Key Dates
Asston Pharmaceuticals Limited IPO IPO Review & Analysis
Should I Apply for Asston Pharmaceuticals Limited IPO?
The Asston Pharmaceuticals Limited IPO decision depends on your risk tolerance, investment goals, and analysis of company fundamentals. Consider factors like business model, financial performance, industry prospects, and valuation before applying.
Key Positives
- • SME listing provides credibility
- • Issue size of ₹27.56 Cr indicates scale
- • Regulated by SEBI guidelines
Key Considerations
- • Analyze company financials thoroughly
- • Check Grey Market Premium trends
- • Consider market conditions
Asston Pharmaceuticals Limited IPO Allotment Details
Allotment Timeline
How to Check Allotment
- • Visit registrar's official website
- • Enter PAN or application number
- • Check through broker's platform
- • Use our universal allotment tracker
Tip: Asston Pharmaceuticals Limited IPO IPO allotment status will be available approximately 2-3 days after the issue closes. Successful applicants will receive shares in their demat account before listing.